Skip to main content
Erschienen in: Heart and Vessels 11/2022

19.05.2022 | Original Article

Malnutrition, hemodynamics and inflammation in heart failure with reduced, mildly reduced and preserved ejection fraction

verfasst von: Yusuke Watanabe, Yu Horiuchi, Masaaki Nakase, Naoto Setoguchi, Taiki Ishizawa, Masahiro Sekiguchi, Hideaki Nonaka, Momoka Nakajima, Masahiko Asami, Kazuyuki Yahagi, Kota Komiyama, Hitomi Yuzawa, Jun Tanaka, Jiro Aoki, Kengo Tanabe

Erschienen in: Heart and Vessels | Ausgabe 11/2022

Einloggen, um Zugang zu erhalten

Abstract

In patients with heart failure (HF) with reduced ejection fraction (HFrEF), malnutrition can be associated with intestinal congestion and systemic inflammation. These relationships have not been fully investigated in HF with mildly reduced EF (HFmrEF) and with preserved EF (HFpEF). We analyzed 420 patients with HF who underwent right heart catheterization. The relationships between hemodynamic parameters, C-reactive protein, and the controlling nutritional (CONUT) score were investigated in HFrEF, HFmrEF and HFpEF. The CONUT score of all patients was 2 [1, 4] (median [interquartile range]), and was not significantly different between the left ventricular EF (LVEF) categories (2 [1, 3] for HFrEF, 2 [1, 3] for HFmrEF, and 3 [1, 4] for HFpEF, p = 0.279). In multivariate linear regression analyses, there was a significant association between CRP and the CONUT score in HFmrEF and HFpEF, while brain natriuretic peptide and right atrial pressure were significantly associated with the CONUT score in HFrEF. Higher CONUT scores predicted a higher incidence of the composite endpoint of death or HF hospitalization within 12 months without an interaction with LVEF (p = 0.980). The CONUT score was an independent predictor of the composite endpoint, death, and HF hospitalization after adjustment for confounders in the multivariate analysis. In conclusion, inflammation was associated with malnutrition in HFmrEF and HFpEF, while congestion was an independent predictor of malnutrition in HFrEF. Malnutrition predicted worse outcomes regardless of LVEF.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN, Yusuf S (2003) Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 361(9363):1077–1083CrossRef Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN, Yusuf S (2003) Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 361(9363):1077–1083CrossRef
2.
Zurück zum Zitat Horiuchi Y, Tanimoto S, Okuno T, Aoki J, Yahagi K, Sato Y, Tanaka T, Koseki K, Komiyama K, Nakajima H, Hara K, Tanabe K (2018) Hemodynamic correlates of nutritional indexes in heart failure. J Cardiol 71(6):557–563CrossRef Horiuchi Y, Tanimoto S, Okuno T, Aoki J, Yahagi K, Sato Y, Tanaka T, Koseki K, Komiyama K, Nakajima H, Hara K, Tanabe K (2018) Hemodynamic correlates of nutritional indexes in heart failure. J Cardiol 71(6):557–563CrossRef
3.
Zurück zum Zitat Santos NFD, Pinho CPS, Cardoso A, Mendes RML (2018) Cachexia in hospitalized patients with heart failure. Nutr Hosp 35(3):669–676PubMed Santos NFD, Pinho CPS, Cardoso A, Mendes RML (2018) Cachexia in hospitalized patients with heart failure. Nutr Hosp 35(3):669–676PubMed
4.
Zurück zum Zitat Valentova M, Anker SD, von Haehling S (2020) Cardiac cachexia revisited: the role of wasting in heart failure. Heart Fail Clin 16(1):61–69CrossRef Valentova M, Anker SD, von Haehling S (2020) Cardiac cachexia revisited: the role of wasting in heart failure. Heart Fail Clin 16(1):61–69CrossRef
5.
Zurück zum Zitat Carr JG, Stevenson LW, Walden JA, Heber D (1989) Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 63(11):709–713CrossRef Carr JG, Stevenson LW, Walden JA, Heber D (1989) Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 63(11):709–713CrossRef
6.
Zurück zum Zitat Krack A, Sharma R, Figulla HR, Anker SD (2005) The importance of the gastrointestinal system in the pathogenesis of heart failure. Eur Heart J 26(22):2368–2374CrossRef Krack A, Sharma R, Figulla HR, Anker SD (2005) The importance of the gastrointestinal system in the pathogenesis of heart failure. Eur Heart J 26(22):2368–2374CrossRef
7.
Zurück zum Zitat Pasini E, Aquilani R, Testa C, Baiardi P, Angioletti S, Boschi F, Verri M, Dioguardi F (2016) Pathogenic gut flora in patients with chronic heart failure. JACC Heart Fail 4(3):220–227CrossRef Pasini E, Aquilani R, Testa C, Baiardi P, Angioletti S, Boschi F, Verri M, Dioguardi F (2016) Pathogenic gut flora in patients with chronic heart failure. JACC Heart Fail 4(3):220–227CrossRef
8.
Zurück zum Zitat Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC (2008) Albumin levels predict survival in patients with systolic heart failure. Am Heart J 155(5):883–889CrossRef Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC (2008) Albumin levels predict survival in patients with systolic heart failure. Am Heart J 155(5):883–889CrossRef
9.
Zurück zum Zitat Ignacio de Ulibarri J, Gonzalez-Madrono A, de Villar NG, Gonzalez P, Gonzalez B, Mancha A, Rodriguez F, Fernandez G (2005) CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp 20(1):38–45PubMed Ignacio de Ulibarri J, Gonzalez-Madrono A, de Villar NG, Gonzalez P, Gonzalez B, Mancha A, Rodriguez F, Fernandez G (2005) CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp 20(1):38–45PubMed
10.
Zurück zum Zitat Ommen SR, Hodge DO, Rodeheffer RJ, McGregor CG, Thomson SP, Gibbons RJ (1998) Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. Circulation 97(1):19–22CrossRef Ommen SR, Hodge DO, Rodeheffer RJ, McGregor CG, Thomson SP, Gibbons RJ (1998) Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. Circulation 97(1):19–22CrossRef
11.
Zurück zum Zitat Rauchhaus M, Clark AL, Doehner W, Davos C, Bolger A, Sharma R, Coats AJ, Anker SD (2003) The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol 42(11):1933–1940CrossRef Rauchhaus M, Clark AL, Doehner W, Davos C, Bolger A, Sharma R, Coats AJ, Anker SD (2003) The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol 42(11):1933–1940CrossRef
12.
Zurück zum Zitat Ferrari R, Fucili A, Rapezzi C (2020) Understanding the results of the PARAGON-HF trial. Eur J Heart Fail 22(9):1531–1535CrossRef Ferrari R, Fucili A, Rapezzi C (2020) Understanding the results of the PARAGON-HF trial. Eur J Heart Fail 22(9):1531–1535CrossRef
13.
Zurück zum Zitat Paulus WJ, Tschope C (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62(4):263–271CrossRef Paulus WJ, Tschope C (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62(4):263–271CrossRef
14.
Zurück zum Zitat Peterson PN, Rumsfeld JS, Liang L et al (2010) A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program. Circ Cardiovasc Qual Outcomes 3:25–32CrossRef Peterson PN, Rumsfeld JS, Liang L et al (2010) A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program. Circ Cardiovasc Qual Outcomes 3:25–32CrossRef
15.
Zurück zum Zitat Pocock SJ, Ariti CA, McMurray JJV et al (2013) Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J 34:1404–1413CrossRef Pocock SJ, Ariti CA, McMurray JJV et al (2013) Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J 34:1404–1413CrossRef
16.
Zurück zum Zitat Alibay Y, Schmitt C, Beauchet A, Dubourg O, Alexandre JA, Boileau C, Jondeau G, Puy H (2005) Non-radioimmunometric NT-ProBNP and BNP assays: impact of diluent, age, gender, BMI. Ann Biol Clin (Paris) 63(1):43–49 Alibay Y, Schmitt C, Beauchet A, Dubourg O, Alexandre JA, Boileau C, Jondeau G, Puy H (2005) Non-radioimmunometric NT-ProBNP and BNP assays: impact of diluent, age, gender, BMI. Ann Biol Clin (Paris) 63(1):43–49
17.
Zurück zum Zitat Chien SC, Lo CI, Lin CF, Sung KT, Tsai JP, Huang WH, Yun CH, Hung TC, Lin JL, Liu CY, Hou CJ, Tsai IH, Su CH, Yeh HI, Hung CL (2019) Malnutrition in acute heart failure with preserved ejection fraction: clinical correlates and prognostic implications. ESC Heart Fail 6(5):953–964CrossRef Chien SC, Lo CI, Lin CF, Sung KT, Tsai JP, Huang WH, Yun CH, Hung TC, Lin JL, Liu CY, Hou CJ, Tsai IH, Su CH, Yeh HI, Hung CL (2019) Malnutrition in acute heart failure with preserved ejection fraction: clinical correlates and prognostic implications. ESC Heart Fail 6(5):953–964CrossRef
18.
Zurück zum Zitat Komorita T, Yamamoto E, Sueta D, Tokitsu T, Fujisue K, Usuku H, Nishihara T, Oike F, Takae M, Egashira K, Takashio S, Ito M, Yamanaga K, Arima Y, Sakamoto K, Suzuki S, Kaikita K, Tsujita K (2020) The controlling nutritional status score predicts outcomes of cardiovascular events in patients with heart failure with preserved ejection fraction. Int J Cardiol Heart Vasc 29:100563PubMedPubMedCentral Komorita T, Yamamoto E, Sueta D, Tokitsu T, Fujisue K, Usuku H, Nishihara T, Oike F, Takae M, Egashira K, Takashio S, Ito M, Yamanaga K, Arima Y, Sakamoto K, Suzuki S, Kaikita K, Tsujita K (2020) The controlling nutritional status score predicts outcomes of cardiovascular events in patients with heart failure with preserved ejection fraction. Int J Cardiol Heart Vasc 29:100563PubMedPubMedCentral
19.
Zurück zum Zitat Minamisawa M, Seidelmann SB, Claggett B, Hegde SM, Shah AM, Desai AS, Lewis EF, Shah SJ, Sweitzer NK, Fang JC, Anand IS, O’Meara E, Rouleau JL, Pitt B, Solomon SD (2019) Impact of malnutrition using geriatric nutritional risk index in heart failure with preserved ejection fraction. JACC Heart Fail 7(8):664–675CrossRef Minamisawa M, Seidelmann SB, Claggett B, Hegde SM, Shah AM, Desai AS, Lewis EF, Shah SJ, Sweitzer NK, Fang JC, Anand IS, O’Meara E, Rouleau JL, Pitt B, Solomon SD (2019) Impact of malnutrition using geriatric nutritional risk index in heart failure with preserved ejection fraction. JACC Heart Fail 7(8):664–675CrossRef
20.
Zurück zum Zitat Glezeva N, Baugh JA (2014) Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target. Heart Fail Rev 19(5):681–694CrossRef Glezeva N, Baugh JA (2014) Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target. Heart Fail Rev 19(5):681–694CrossRef
21.
Zurück zum Zitat Anand IS, Latini R, Florea VG, Kuskowski MA, Rector T, Masson S, Signorini S, Mocarelli P, Hester A, Glazer R, Cohn JN, Val-He FTI (2005) C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation 112(10):1428–1434CrossRef Anand IS, Latini R, Florea VG, Kuskowski MA, Rector T, Masson S, Signorini S, Mocarelli P, Hester A, Glazer R, Cohn JN, Val-He FTI (2005) C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation 112(10):1428–1434CrossRef
22.
Zurück zum Zitat Iwanaga Y, Nishi I, Furuichi S, Noguchi T, Sase K, Kihara Y, Goto Y, Nonogi H (2006) B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol 47(4):742–748CrossRef Iwanaga Y, Nishi I, Furuichi S, Noguchi T, Sase K, Kihara Y, Goto Y, Nonogi H (2006) B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol 47(4):742–748CrossRef
23.
Zurück zum Zitat Joaquin C, Alonso N, Lupon J, de Antonio M, Domingo M, Moliner P, Zamora E, Codina P, Ramos A, Gonzalez B, Rivas C, Cachero M, Puig-Domingo M, Bayes-Genis A (2020) Mini Nutritional Assessment Short Form is a morbi-mortality predictor in outpatients with heart failure and mid-range left ventricular ejection fraction. Clin Nutr 39(11):3395–3401CrossRef Joaquin C, Alonso N, Lupon J, de Antonio M, Domingo M, Moliner P, Zamora E, Codina P, Ramos A, Gonzalez B, Rivas C, Cachero M, Puig-Domingo M, Bayes-Genis A (2020) Mini Nutritional Assessment Short Form is a morbi-mortality predictor in outpatients with heart failure and mid-range left ventricular ejection fraction. Clin Nutr 39(11):3395–3401CrossRef
24.
Zurück zum Zitat Agra Bermejo RM, Gonzalez Ferreiro R, Varela Roman A, Gomez Otero I, Kreidieh O, Conde Sabaris P, Rodriguez-Manero M, Moure Gonzalez M, Seoane Blanco A, Virgos Lamela A, Garcia Castelo A, Gonzalez Juanatey JR (2017) Nutritional status is related to heart failure severity and hospital readmissions in acute heart failure. Int J Cardiol 230:108–114CrossRef Agra Bermejo RM, Gonzalez Ferreiro R, Varela Roman A, Gomez Otero I, Kreidieh O, Conde Sabaris P, Rodriguez-Manero M, Moure Gonzalez M, Seoane Blanco A, Virgos Lamela A, Garcia Castelo A, Gonzalez Juanatey JR (2017) Nutritional status is related to heart failure severity and hospital readmissions in acute heart failure. Int J Cardiol 230:108–114CrossRef
25.
Zurück zum Zitat Iwakami N, Nagai T, Furukawa TA, Sugano Y, Honda S, Okada A, Asaumi Y, Aiba T, Noguchi T, Kusano K, Ogawa H, Yasuda S, Anzai T, Defi N (2017) Prognostic value of malnutrition assessed by controlling nutritional status score for long-term mortality in patients with acute heart failure. Int J Cardiol 230:529–536CrossRef Iwakami N, Nagai T, Furukawa TA, Sugano Y, Honda S, Okada A, Asaumi Y, Aiba T, Noguchi T, Kusano K, Ogawa H, Yasuda S, Anzai T, Defi N (2017) Prognostic value of malnutrition assessed by controlling nutritional status score for long-term mortality in patients with acute heart failure. Int J Cardiol 230:529–536CrossRef
26.
Zurück zum Zitat Kato T, Yaku H, Morimoto T, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Seko Y, Inoko M, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Ozasa N, Kimura T (2020) Association with Controlling Nutritional Status (CONUT) score and in-hospital mortality and infection in acute heart failure. Sci Rep 10(1):3320CrossRef Kato T, Yaku H, Morimoto T, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Seko Y, Inoko M, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Ozasa N, Kimura T (2020) Association with Controlling Nutritional Status (CONUT) score and in-hospital mortality and infection in acute heart failure. Sci Rep 10(1):3320CrossRef
27.
Zurück zum Zitat Narumi T, Arimoto T, Funayama A, Kadowaki S, Otaki Y, Nishiyama S, Takahashi H, Shishido T, Miyashita T, Miyamoto T, Watanabe T, Kubota I (2013) Prognostic importance of objective nutritional indexes in patients with chronic heart failure. J Cardiol 62(5):307–313CrossRef Narumi T, Arimoto T, Funayama A, Kadowaki S, Otaki Y, Nishiyama S, Takahashi H, Shishido T, Miyashita T, Miyamoto T, Watanabe T, Kubota I (2013) Prognostic importance of objective nutritional indexes in patients with chronic heart failure. J Cardiol 62(5):307–313CrossRef
28.
Zurück zum Zitat Nochioka K, Sakata Y, Takahashi J, Miyata S, Miura M, Takada T, Fukumoto Y, Shiba N, Shimokawa H, Investigators C (2013) Prognostic impact of nutritional status in asymptomatic patients with cardiac diseases: a report from the CHART-2 Study. Circ J 77(9):2318–2326CrossRef Nochioka K, Sakata Y, Takahashi J, Miyata S, Miura M, Takada T, Fukumoto Y, Shiba N, Shimokawa H, Investigators C (2013) Prognostic impact of nutritional status in asymptomatic patients with cardiac diseases: a report from the CHART-2 Study. Circ J 77(9):2318–2326CrossRef
29.
Zurück zum Zitat Dorsheimer L, Assmus B, Rasper T, Ortmann CA, Ecke A, Abou-El-Ardat K, Schmid T, Brune B, Wagner S, Serve H, Hoffmann J, Seeger F, Dimmeler S, Zeiher AM, Rieger MA (2019) Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure. JAMA Cardiol 4(1):25–33CrossRef Dorsheimer L, Assmus B, Rasper T, Ortmann CA, Ecke A, Abou-El-Ardat K, Schmid T, Brune B, Wagner S, Serve H, Hoffmann J, Seeger F, Dimmeler S, Zeiher AM, Rieger MA (2019) Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure. JAMA Cardiol 4(1):25–33CrossRef
30.
Zurück zum Zitat Lee MS, Duan L, Clare R, Hekimian A, Spencer H, Chen W (2018) Comparison of effects of statin use on mortality in patients with heart failure and preserved versus reduced left ventricular ejection fraction. Am J Cardiol 122(3):405–412CrossRef Lee MS, Duan L, Clare R, Hekimian A, Spencer H, Chen W (2018) Comparison of effects of statin use on mortality in patients with heart failure and preserved versus reduced left ventricular ejection fraction. Am J Cardiol 122(3):405–412CrossRef
31.
Zurück zum Zitat Preiss D, Campbell RT, Murray HM, Ford I, Packard CJ, Sattar N, Rahimi K, Colhoun HM, Waters DD, LaRosa JC, Amarenco P, Pedersen TR, Tikkanen MJ, Koren MJ, Poulter NR, Sever PS, Ridker PM, MacFadyen JG, Solomon SD, Davis BR, Simpson LM, Nakamura H, Mizuno K, Marfisi RM, Marchioli R, Tognoni G, Athyros VG, Ray KK, Gotto AM, Clearfield MB, Downs JR, McMurray JJ (2015) The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials. Eur Heart J 36(24):1536–1546CrossRef Preiss D, Campbell RT, Murray HM, Ford I, Packard CJ, Sattar N, Rahimi K, Colhoun HM, Waters DD, LaRosa JC, Amarenco P, Pedersen TR, Tikkanen MJ, Koren MJ, Poulter NR, Sever PS, Ridker PM, MacFadyen JG, Solomon SD, Davis BR, Simpson LM, Nakamura H, Mizuno K, Marfisi RM, Marchioli R, Tognoni G, Athyros VG, Ray KK, Gotto AM, Clearfield MB, Downs JR, McMurray JJ (2015) The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials. Eur Heart J 36(24):1536–1546CrossRef
Metadaten
Titel
Malnutrition, hemodynamics and inflammation in heart failure with reduced, mildly reduced and preserved ejection fraction
verfasst von
Yusuke Watanabe
Yu Horiuchi
Masaaki Nakase
Naoto Setoguchi
Taiki Ishizawa
Masahiro Sekiguchi
Hideaki Nonaka
Momoka Nakajima
Masahiko Asami
Kazuyuki Yahagi
Kota Komiyama
Hitomi Yuzawa
Jun Tanaka
Jiro Aoki
Kengo Tanabe
Publikationsdatum
19.05.2022
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 11/2022
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-022-02090-3

Weitere Artikel der Ausgabe 11/2022

Heart and Vessels 11/2022 Zur Ausgabe

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.